FLT3 targeting in the modern era: from clonal selection to combination therapies. Kennedy VE, Smith CC. Int J Hematol 2024;120:528-540.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kennedy VE, Smith CC. FLT3 targeting in the modern era: from clonal selection to combination therapies. Int J Hematol 2024;120:528-540.
PMID: 38112995